Skip to main content

Table 1 Clinicopathological characteristics of the patients with cervical squamous cell carcinoma in the RT-sensitive group (CC-RS) and RT-resistant (CC-RR) group

From: Inhibition of Delta-like Ligand 4 enhances the radiosensitivity and inhibits migration in cervical cancer via the reversion of epithelial–mesenchymal transition

Variables

No. patients

(N = 20)

Radiosensitivity

CC-RS

(N = 10)

CC-RR

(N = 10)

Age (years)

 <  45

13

6 (46.2)

7 (53.8)

 ≥ 45

7

4 (57.1)

3 (42.9)

FIGO stage

 IIIa

8

3 (37.5)

5 (62.5)

 IIIb

12

7 (58.3)

5 (41.7)

SCC-Ag value

 1.5–10

15

7 (46.7)

8 (53.3)

 > 10

5

3 (60.0)

2 (40.0)

Tumor size(cm)

 ≤ 4

14

6 (42.9)

8 (57.1)

 > 4

6

4 (66.7)

2 (33.3)

Deep stromal invasion

 No

5

3 (60.0)

2 (40.0)

 Yes

15

7 (46.7)

8 (53.3)

Pelvic lymph node metastasis

 No

12

7 (58.3)

5 (41.7)

 Yes

8

3 (37.5)

5 (62.5)

  1. CC-RS cervical cancer patients in RT-sensitive group, CC-RR cervical cancer patients in RT-resistant group, FIGO Federation International of Gynecology and Obstetrics, SCC squamous cell carcinoma